Form 4 for GENB Generate Biomedicines, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-085898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-03-02 | 2026-03-02 | GENB | Silvers Jason | Pres, CFO | P - Purchase | $16.00 | +2,000 | 500 | New | +$32.0K |
| DM | 2026-03-02 | 2026-02-26 | GENB | Silvers Jason | Pres, CFO | A - Grant | $0.00 | +570.1K | 295.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | P | A | 1,000 | $16.00 | 1,000 | I By son | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | P | A | 500 | $16.00 | 500 | I By daughter | — | — | |
| 3 | Common | Common Stock | 2026-03-02 | P | A | 500 | $16.00 | 500 | I By daughter | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-26 | A | A | 274,493 | $0.00 | 274,493 | D | $16.00 · — to 2036-02-25 | 274,493 Common Stock | (F2) The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-26 | A | A | 295,608 | $0.00 | 295,608 | D | $16.00 · — to 2036-02-25 | 295,608 Common Stock | (F1) The shares underlying this option shall vest in two equal installments on each of February 19, 2029 and February 19, 2030, subject to the Reporting Person's continued service on each such vesting date. |